GLYCOTEST

Glycotest is a liver disease diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis. Founded in 2012 by NetScientific plc on technology innovated by two experts in the fields of liver disease and glycobiology−Professors Timothy Block and Anand Mehta at Drexel University College of Medicine and the Baruch S. Blumberg Institute, we have exclusive, world-wide rights to over 50 patent-protected serum glycoprotein biomarkers, biomarker panels and algorithms, and novel assay technology that exploit sugar-based disease signals. The Company's lead test for curable early-stage liver cancer has significantly outperformed the current standard blood test in multiple preliminary clinical studies. Our mission is to revolutionize the care and treatment of the at-risk chronic liver disease population, including the rapidly growing population with NASH... Glycotest Diagnostics | Developing unique and non-invasive blood tests for liver..

Also known as: Glycotest, Inc

Primary location: Merion United States